Good morning :)
Switch to
Place Order

Lyka Labs Ltd

LYKALABS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹226 cr, stock is ranked 1,516
High RiskStock is 3.77x as volatile as Nifty
78.951.40 (-1.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹226 cr, stock is ranked 1,516
High RiskStock is 3.77x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-19.61
PB RatioPB Ratio
-9.29
Dividend YieldDiv. Yield
Sector PESector PE
39.35
Sector PBSector PB
5.27
Sector Div YldSctr Div Yld
0.65%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lyka Labs Limited is a pharmaceutical products and services provider. The Company is primarily engaged in formulation and manufacturing lyophilized products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202165.3972.8766.3387.81-17.27-5.56-60.54-11.55
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Change in Director(s) 
Announced OnAug 4, 2021

Lyka Labs Limited has informed the Exchange regarding Change in Director(s) of the company. | Download

Lyka Labs Limited has informed the Exchange regarding Change in Director(s) of the company. | Download

Appointment 
Announced OnAug 4, 2021

Lyka Labs Limited has informed the Exchange regarding Appointment of Mrs Dhara P. Shah as Non- Executive Independent Director of the company w.e.f. August 04, 2021. | Download

Lyka Labs Limited has informed the Exchange regarding Appointment of Mrs Dhara P. Shah as Non- Executive Independent Director of the company w.e.f. August 04, 2021. | Download

Financial Result Updates 
Announced OnAug 4, 2021

Lyka Labs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021. | Download

Lyka Labs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021. | Download

See all events